Jul 24, 2025 The Dermatology Digest: U.S. FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx-Melanoma Test
Jul 23, 2025 Dermatology Times: Castle Biosciences’ DecisionDx-Melanoma Test Earns FDA Breakthrough Device Designation
Jul 15, 2025 Clinical Lab Products: Improving Barrett's Esophagus Risk Stratification with AI-Powered Spatialomics
Jul 14, 2025 CEO Magazine: Meet the finalists for the 2025 Executive of the Year Awards – United States
Jul 1, 2025 Dermatology Times: Gene Expression Profiling Guides Individualized Management in Melanoma and SCC
